Skip to main content
SpringerLink
Log in

Assessing Human and Economic Benefits of Cancer Prevention

  • Chapter
Fundamentals of Cancer Prevention

  • 645 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aaronson, N.K., S. Ahmedzai, et al. (1993). "The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology." J Natl Cancer Inst 85(5): 365–376.

    PubMed  Google Scholar 

  • Bowling, A. (1997). Measuring Health: A Review of Quality of Life Measurement Scales. Philadelphia, Open University Press.

    Google Scholar 

  • Bowling, A. (2001). Measuring Disease: A Review of Disease-Specific Quality of Life Measurement Scales. Philadelphia, Open University Press.

    Google Scholar 

  • Brazier, J., J. Roberts, et al. (2002). "The estimation of a preference-based measure of health from the SF-36." J Health Econ 21(2): 271–292.

    Article  PubMed  Google Scholar 

  • Brown, A.D. and A.M. Garber (1999). "Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing." JAMA 281(4): 347–353.

    Article  PubMed  Google Scholar 

  • Brown, M. L., J. Lipscomb, et al. (2001). "The burden of illness of cancer: economic cost and quality of life." Annu Rev Public Health 22: 91–113.

    Article  PubMed  Google Scholar 

  • Bruner, D.W., B. Movsas, et al. (2004). "Outcomes research in cancer clinical trial cooperative groups: the RTOG model." Qual Life Res 13(6): 1025–1041.

    Article  PubMed  Google Scholar 

  • Cella, D. F., D.S. Tulsky, et al. (1993). "The Functional Assessment of Cancer Therapy scale: development and validation of the general measure." J Clin Oncol 11(3): 570–579.

    PubMed  Google Scholar 

  • Cullen, J., M.D. Schwartz, et al. (2004). "Short-term impact of cancer prevention and screening activities on quality of life." J Clin Oncol 22(5): 943–952.

    Article  PubMed  Google Scholar 

  • Day, R., P.A. Ganz, et al. (1999). "Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study." J Clin Oncol 17(9): 2659–2669.

    PubMed  Google Scholar 

  • Donaldson, M.S. (2004). "Taking stock of health-related quality-of-life measurement in oncology practice in the United States." J Natl Cancer Inst Monogr (33): 155–167.

    Article  PubMed  Google Scholar 

  • Eddy, D.M. (1990). "Screening for cervical cancer." Ann Intern Med 113(3): 214–226.

    PubMed  Google Scholar 

  • Esser, M. and H. Brunner (2003). "Economic evaluations of granulocyte colony-stimulating factor: in the prevention and treatment of chemotherapy-induced neutropenia." Pharmacoeconomics 21(18): 1295–1313.

    PubMed  Google Scholar 

  • Fryback, D.G. and B.M. Craig (2004). "Measuring economic outcomes of cancer." J Natl Cancer Inst Monogr (33): 134–141.

    Article  PubMed  Google Scholar 

  • Gelber, R.D., A. Goldhirsch, et al. (1993). "Evaluation of effectiveness: Q-TWiST The International Breast Cancer Study Group." Cancer Treat Rev 19Suppl A: 73–84.

    Article  PubMed  Google Scholar 

  • Goldie, S.J., M. Kohli, et al. (2004). "Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine." J Natl Cancer Inst 96(8): 604–615.

    PubMed  Google Scholar 

  • Goldie, S.J., M.C. Weinstein, et al. (1999). "The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women." Ann Intern Med 130(2): 97–107.

    PubMed  Google Scholar 

  • Guyatt, G.H., D. H. Feeny, et al. (1993). "Measuring health-related quality of life." Ann Intern Med 118(8): 622–629.

    PubMed  Google Scholar 

  • Houts, P.S., A. Lipton, et al. (1984). "Nonmedical costs to patients and their families associated with outpatient chemotherapy." Cancer 53(11): 2388–2392.

    PubMed  Google Scholar 

  • Johnson, E., F. Dominici, M. Griswold, S. L. Zeger (2003). "Disease cases and their medical costs attributable to smoking: an analysis of the national medical expenditure survey." Journal of Econometrics 112(1): 135–151.

    Article  MathSciNet  Google Scholar 

  • Karnofsky, D., J. Burchenal (1949). The clinical evaluation of chemotherapeutic agents in cancer. Evaluation of Chemotherapeutic Agents. C. Macleod. New York, Columbia University Press.

    Google Scholar 

  • Kozma, C.M., C.E. Reeder, et al. (1993). "Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research." Clin Ther 15(6): 1121–1132; discussion 1120.

    PubMed  Google Scholar 

  • Kulasingam, S. L. and E. R. Myers (2003). "Potential health and economic impact of adding a human papillomavirus vaccine to screening programs." Jama 290(6): 781–789.

    Article  PubMed  Google Scholar 

  • Lipscomb, J., M.S. Donaldson, et al. (2004). "Cancer outcomes research and the arenas of application." J Natl Cancer Inst Monogr(33): 1–7.

    Article  PubMed  Google Scholar 

  • Lipscomb, J. and C.F. Snyder (2002). "The Outcomes of Cancer Outcomes Research: focusing on the National Cancer Institute's quality-of-care initiative." Med Care 40(6 Suppl): III3–10.

    Article  PubMed  Google Scholar 

  • Litwin, M. S., R.D. Hays, et al. (1998). "The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure." Med Care 36(7): 1002–1012.

    Article  PubMed  Google Scholar 

  • Loeve, F., M. L. Brown, et al. (2000). "Endoscopic colorectal cancer screening: a cost-saving analysis." J Natl Cancer Inst 92(7): 557–563.

    Article  PubMed  Google Scholar 

  • Mandelblatt, J.S., W.F. Lawrence, et al. (2002). "Benefits and costs of using HPV testing to screen for cervical cancer." JAMA 287(18): 2372–2381.

    Article  PubMed  Google Scholar 

  • McDowell, I., C. Newell (1996). Measuring Health: A Guide to Rating Scales and Questionnaires. Philadelphia, Oxford University Press.

    Google Scholar 

  • NCI (2004). Cancer Progress Report — 2003 Update. Rockville, National Cancer Institute.

    Google Scholar 

  • O'Brien, B.J., J. Rusthoven, et al. (1993). "Impact of chemotherapy-associated nausea and vomiting on patients' functional status and on costs: survey of five Canadian centres." CMAJ 149(3): 296–302.

    PubMed  Google Scholar 

  • Patrick, D.L. and R.A. Deyo (1989). "Generic and disease-specific measures in assessing health status and quality of life." Med Care 27(3 Suppl): S217–232.

    PubMed  Google Scholar 

  • Ramsey, S.D., M.T. Mandelson, et al. (2003). "Cancer-attributable costs of diagnosis and care for persons with screen-detected versus symptom-detected colorectal cancer." Gastroenterology 125(6): 1645–1650.

    Article  PubMed  Google Scholar 

  • Schron, E.B. and S.A. Shumaker (1992). "The integration of health quality of life in clinical research: experiences from cardiovascular clinical trials." Prog Cardiovasc Nurs 7(1): 21–28.

    Google Scholar 

  • Sculpher, M., M.K. Palmer, et al. (2000). "Costs incurred by patients undergoing advanced colorectal cancer therapy. A comparison of raltitrexed and fluorouracil plus folinic acid." Pharmacoeconomics 17(4): 361–370.

    PubMed  Google Scholar 

  • Staquet, M., N. Aaronson, et al. (1992). "Health-related quality of life research." Qual Life Res 1:3.

    Article  PubMed  Google Scholar 

  • Taplin, S.H., W. Barlow, et al. (1995). "Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care." J Natl Cancer Inst 87(6): 417–426.

    PubMed  Google Scholar 

  • Tengs, T.O. and A. Wallace (2000). "One thousand health-related quality-of-life estimates." Med Care 38(6): 583–637.

    Article  PubMed  Google Scholar 

  • Till, J.E., McNeil, B.J., Bush, R.S. (1984). "Measurement of multiple components of quality of life." Cancer Treatment Symposia 1: 177–181.

    Google Scholar 

  • Tsao, H., G.S. Rogers, et al. (1998). "An estimate of the annual direct cost of treating cutaneous melanoma." J Am Acad Dermatol 38(5 Pt 1): 669–680.

    PubMed  Google Scholar 

  • Ubel, P. (2001). Pricing Life: Why it's Time for Health Care Rationing. Cambridge, MIT Press.

    Google Scholar 

  • Wagner, J.L. (1997). "Cost-effectiveness of screening for common cancers." Cancer Metastasis Rev 16(3–4): 281–294.

    Article  PubMed  Google Scholar 

  • Ware, J., M. Kosinski, S. Keller (1994). SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, The Health Institute.

    Google Scholar 

  • Ware, J.E., Jr. and C.D. Sherbourne (1992). "The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection." Med Care 30(6): 473–483.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy, University of Arizona, Tucson, AZ, 85721

    Stephen Joel Coons & Benjamin M. Craig

Authors
  1. Stephen Joel Coons
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Benjamin M. Craig
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cancer Prevention and Control, Arizona Cancer Center, 1515 N. Campbell Avenue, PO Box 245024, Tuscon, AZ, 85724

    David S. Alberts  & Lisa M. Hess  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Berlin Heidelberg

About this chapter

Cite this chapter

Coons, S.J., Craig, B.M. (2005). Assessing Human and Economic Benefits of Cancer Prevention. In: Alberts, D.S., Hess, L.M. (eds) Fundamentals of Cancer Prevention. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26337-3_2

Download citation

  • DOI: https://doi.org/10.1007/3-540-26337-3_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-24212-3

  • Online ISBN: 978-3-540-26337-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation